Aprea Therapeutics, Inc. (APRE)
NASDAQ·Healthcare·Biotechnology
$0.78
+6.79%
Mkt Cap $9.58M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$0.78
+6.79%
Mkt Cap $9.58M
Buy
4
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —